MMED

16.1000.98%
DK

D. Keith Grossman

Lead Independent Director

Mr. D. Keith Grossman is Director of Supira Medical, Inc. from April 2026. He is Independent Director of Minimed Group, Inc. from March 6, 2026. Mr. Grossman served as Non-Executive Chairman of the Board of Nevro Corp. from October 2023 until April 3, 2025. He served as President and Chief Executive Officer of Nevro Corp. since March 19, 2019 until April 24, 2023 and serves as its Director since March 19, 2019 and had been its Chairman of the Board since May 20, 2019 until April 24, 2023 and served as its Executive Chairman since April 24, 2023 until October 2023. He has been an Independent Director of Alcon, Inc since 2019 and also serves as its Vice Chair. He is the Director & Vice Chair at Alcon Vision, LLC. He served as the Chief Executive Officer and President of Thoratec Corp. from September 22, 2014 to December 2015 and from January 1996 to January 2006. Mr. Grossman served as the Chief Executive Officer and President of Conceptus, Inc. from December 8, 2011 to June 2013. Prior to Conceptus, Mr. Grossman served as Managing Director and Senior Advisor at TPG Growth, TPG Biotechnology Partners III, L.P. and TPG Biotechnology Partners L.P. from September 2007 to December 2011. He served as the Chief Executive Officer of International Technidyne Corp. He joined TPG in 2007. He served as Division President of Major Pharmaceuticals Inc. from June 1992 to September 1995. From July 1988 to June 1992, he served as Vice President, Sales and Marketing of Calcitek Inc. He served various other sales and marketing management positions within McGaw Laboratories Division of American Hospital Supply Corporation. He has experience in the medical device industry, International Supply Chain and Technology. He serves as Lead Independent Director at Outset Medical, Inc. since February 2022 and had been the Independent Chairman of the Board since April 2014 until February 2022 and serves as its Independent Director since 2014. He served as the Chairman of the Board of NovaSom, Inc. since March 2008. He has been a Director at TherOx, Inc. since February 2016. He serves as a Director of Centerpulse Ltd. He serves as a Director of Tandem Diabetes Care, Inc. from April 2010 to January 2012. He served as a Director of Acorn Cardiovascular Inc. He served as a Director of Thoratec Corp. from February 1996 to October 8, 2015. Mr. Grossman served as a Director of ZELTIQ Aesthetics, Inc (acquired by Allergan). since October 2013 until May 2017 and served its Lead Independent Director since February 2016 until April 28, 2017. Mr. Grossman served as a Director at Conceptus, Inc. from December 8, 2011 to June 5, 2013. Mr. Grossman has served as Vice Chairman of Alcon Laboratories, a subsidiary of Novartis AG focused on eye care products, since April 2019. He also previously held positions with Eon Labs, a pharmaceutical company and SulzerMedica, a manufacturer of implantable medical devices. He served a variety of roles within numerous public and private Board of Directors memberships, including medical technology companies Intuitive Surgical and at Kyphon (acquired by Medtronic) from May 2007 to November 2007. He had been Director of ViewRay, Inc. since July 24, 2018 until February 9, 2021. He served as a Director at Medtronic Spine LLC since April 25, 2007. He served as a Director of Intuitive Surgical Inc. from April 2003 to April 21, 2010 and PatientSafe Solutions, Inc. Mr. Grossman holds a B.S. in Animal Sciences from Ohio State University and an M.B.A. in Finance from the George L. Graziadio School of Business and Management, Pepperdine University.

公司职务